Sonova Holding AG
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Sonova Holding AG develops, manufactures and markets innovative hearing care solutions including hearing aids, cochlear implants, consumer hearing devices, audiological care services and wireless communication systems. The company operates through four main businesses: Hearing Instruments offering behind-the-ear (BTE), receiver-in-canal (RIC), custom in-the-ear (ITE) and rechargeable ITE hearing aids such as Phonak Audéo Infinio, Infinio Ultra, Infinio Sphere, Virto R Infinio and Unitron brands; Audiological Care providing hearing care services through retail networks like AudioNova and Connect Hearing; Consumer Hearing featuring personal audio devices and Sennheiser licensed products including true wireless earbuds; Cochlear Implants delivering systems, upgrades and accessories via Advanced Bionics. Sonova maintains research facilities in Switzerland, Canada and the US, manufacturing in Switzerland, China, Vietnam and Mexico, and distributes through in-house wholesale, independent partners and retail outlets serving over 100 countries across Europe, Middle East, Africa, Americas and Asia-Pacific; the group employs over 18,000 people and generated CHF 3.9 billion in sales for the 2024/25 financial year. Founded in 1947 and headquartered in Stäfa, Switzerland, Sonova traces its origins to AG für Elektroakustik and Phonak AG, listing on the Swiss Exchange in 1994 after renaming from Phonak Holding AG in 2007. Recent developments include launches of AI-enhanced Infinio Ultra and Virto R Infinio platforms in 2025 strengthening speech understanding and connectivity; bolt-on acquisitions expanding Audiological Care in Australia, Canada, Germany and France; structural optimizations and cost initiatives in Audiological Care with Mexico facility enhancements; organizational restructuring to a four-region model starting November 2025 for customer-centric growth; CEO transition with Arnd Kaldowski stepping down September 2025 and Eric Bernard assuming role October 2025; ranking 12th among Europe's most innovative companies in 2025 by Fortune.
GMED vs. SONVY: Which Stock Is the Better Value Option?
Sonova Holding AG (SONVY) Q4 2026 Earnings Call Transcript
Sonova Holding (OTCMKTS:SONVY) Given Consensus Recommendation of “Moderate Buy” by Analysts
Sonova Holding AG (SONVY) Discusses Refreshed Strategy and Vision for Next Phase of Growth Transcript
SONVY vs. IDXX: Which Stock Should Value Investors Buy Now?
Short Interest in Sonova Holding (OTCMKTS:SONVY) Expands By 41.2%
SONVY or IDXX: Which Is the Better Value Stock Right Now?
Sonova expects FY revenue at lower end of target range, CEO says in interview
Short Interest in Sonova Holding (OTCMKTS:SONVY) Increases By 219.5%
Sonova Holding (OTCMKTS:SONVY) Short Interest Up 426.1% in December
HOLX vs. SONVY: Which Stock Should Value Investors Buy Now?
HOLX or SONVY: Which Is the Better Value Stock Right Now?
HOLX vs. SONVY: Which Stock Is the Better Value Option?
Sonova Holding (OTCMKTS:SONVY) Receives Consensus Recommendation of “Hold” from Brokerages
Sonova Holding (OTCMKTS:SONVY) Receives Consensus Rating of “Reduce” from Analysts
Sonova Holding AG (SONVY) Q2 2026 Earnings Call Transcript
SONOVA HOLDING (SONVY) Upgraded to Strong Buy: What Does It Mean for the Stock?
GMED vs. SONVY: Which Stock Is the Better Value Option?
ITGR or SONVY: Which Is the Better Value Stock Right Now?
ITGR vs. SONVY: Which Stock Is the Better Value Option?